Skip to Main Content
Q+A

Preventing Infections in Health Care Settings

Turning Evidence Into Practice

6 Minute Read

Health care-associated infections, or infections that patients acquire while receiving treatment in a hospital or other setting, remain a persistent challenge, affecting patient outcomes and contributing to significant illness and cost. They can complicate recovery, prolong hospital stays, and increase the risk of serious illness or death.

While research has identified effective strategies to prevent the spread of infections in hospitals, consistently applying these practices in real-world settings remains challenging.

David Calfee, MD, professor of medicine (infectious diseases) at Yale School of Medicine, has spent his career working to close that gap. His work centers on translating evidence into practice and understanding the systems and behaviors that shape infection risk.

In a Q&A, Calfee, who is also the enterprise chief epidemiologist for Yale New Haven Health System, discusses how the field of health care-associated infection prevention is evolving, the challenges of implementing best practices in real-world settings, and the growing recognition of factors, such as social determinants of health, in shaping transmission risk.

What are some common misconceptions that clinicians and patients have about health care-associated infections?

David Calfee, MD: Infection prevention is often reduced to hand hygiene, with the perception that we are the "hand hygiene police" going around telling people to wash their hands. Hand hygiene is an important part of what we do, but there is much more to it. There has been a great deal of research that has led to evidence-based practices to prevent transmission and infection. Many of these interventions rely on human behavior, things that need to happen correctly over and over again, whether it is hand hygiene, accessing a catheter in a sterile way, or prescribing antibiotics appropriately. At each step, small deviations can increase risk.

Much of infection prevention is really about systems and understanding what gets in the way of doing the right thing, then making that the easiest and most reliable option. It is rarely about an individual failing. More often, there are structural or knowledge gaps that need to be addressed. Infectious disease control is complex, and it really is the responsibility of everyone in health care.

What strategies have been most effective in building a culture of infection prevention across the health system?

Calfee: A lot of it comes down to how you approach people. It’s less about telling someone they did something wrong and more about trying to understand why something is happening or why it’s a challenge. Too often, we create processes that do not fit into real workflows. Small changes, like bundling supplies for procedures or placing hand sanitizer in more intuitive locations, can make it much easier for people to do the right thing consistently. You really have to observe and work alongside people to understand those barriers.

It is also important to explain the “why” behind infection prevention practices. It cannot just be “do this because we say so.” People want to understand the evidence, the benefits, and even the trade-offs.

How has the field of health care-associated infection prevention evolved over the past decade, and where have you seen the most meaningful progress?

Calfee: One major shift over the past decade has been a greater focus on implementation, specifically how we get evidence-based practices to the bedside. There is a well-known estimate that it can take an average of 17 years for a new intervention to be reliably adopted in clinical practice, which is a long time. A big part of the field now is thinking about how we can translate what we know works into real-world care more quickly.

There has also been important progress in reducing high-impact infections. Earlier efforts have focused on targeting device-associated conditions like central line-associated bloodstream infections, catheter-associated urinary tract infections, and surgical site infections. More recently, the field has begun to focus on less-studied areas of prevention. For example, non-ventilator hospital-acquired pneumonia is just as serious as ventilator-associated pneumonia and several times more common, yet it has received far less attention.

Some people are hesitant to come to the hospital because they worry about getting an infection. How can they play a role in infection prevention?

Calfee: There are a number of things patients, as well as their family members and visitors, can do to help reduce risk of infection. Hand hygiene is one example we emphasize with health care workers, but it is also important for patients and visitors. For patients with surgical wounds or medical devices, understanding how to care for them properly, especially after leaving the hospital, is also critical.

It is also important that patients understand the reasoning behind certain parts of their care. For example, practices like daily bathing with chlorhexidine in the hospital can reduce the risk of infections, including central line-associated bloodstream infections. Sometimes patients may feel too tired or unwell to participate, which is completely understandable, but helping them understand that these measures are part of their treatment, not just routine tasks, allows them to make more informed decisions.

A lot of this comes back to making sure patients have the information they need. When patients understand why these practices matter, they are better able to participate in their care and help reduce their risk of infection.

What areas of infection prevention research or innovation are you most excited about right now?

Calfee: I am particularly excited about the growing focus on the role of social determinants of health in health care-associated infections. Factors like the conditions in which people live, work, and access care can certainly shape disease risk before patients enter the hospital. However, increasing evidence also suggests that some of these influences may persist even during hospitalization. This is an area that our field has started to explore more closely in recent years.

For example, some hospitals have found that patients who speak a language other than English may have higher rates of infection while hospitalized. This may relate to challenges with communication, patient education, and the ability to ask questions or engage in more nuanced conversations about how to reduce their risk of catching any germs.

Understanding and addressing these factors is an important next step for the field, particularly as we think about how to make infection prevention within hospitals more equitable and effective for all patients.

Another development that is getting a lot of attention is artificial intelligence. There is great interest in using this technology to help with many aspects of infection prevention, including surveillance, assessment of adherence to recommended practices, prediction of infection risk, and detection of previously unrecognized transmission pathways.

Article outro

Author

Jordan Shaked
Communications Intern, Internal Medicine

Tags

Media Contact

For media inquiries, please contact us.

Learn more about the Yale Department of Internal Medicine

Visit the department website

Explore More

Featured in this article

Related News